Search results for "Highlights"


 
Results 51 - 60 of about 346 for "Highlights".

Highlights

Our analyses demonstrate the therapeutic potential of IF as a weight reduction strategy in [type 2 diabetes] and highlight the need for further research in this field,” the authors wrote.
January 2021

Highlights

ACP recommended that clinicians prescribe metformin for type 2 diabetes when pharmacologic therapy is needed to improve glycemic control in a strong recommendation based on moderate-quality evidence.
January 2017

Highlights

These results clearly highlight the need to respect existing recommendations for dose reduction of sulphonylureas when initiating treatment with DPP-4 inhibitors, and the urgency to determine the efficacy of this
May 2016

Highlights

An editorial accompanying the two trials of continuous glucose monitoring stressed that the physicians involved had extensive experience with the technology and noted that the necessary changes in lifestyle and insulin dosing can be variable and
February 2017

Highlights

The intervention for Medicare beneficiaries with prediabetes includes at least 16 weekly hour-long sessions over months 1 to 6 and at least 6 monthly maintenance sessions over months 6 to 12.
November 2016

Highlights

The blood glucose awareness training involved three 2.5-hour group sessions over 4 weeks plus 2 online modules to be done between group meetings.
November 2016

Highlights

Non-endocrinologist clinicians who electronically ordered glargine at a dose of 0.5 units/kg or greater incurred a warning screen, which advised either lowering the dose or contacting the diabetes consult service for approval.
September 2016

Keeping tabs

Our findings highlight poorly controlled diabetes and its cardiovascular complications as ideal targets for interventions to prevent cognitive impairment or arrest its progression to dementia—conditions for which no curative treatment
November 2021

Highlights

Elevations in high-sensitivity troponin T or N-terminal pro-B-type natriuretic peptide were significantly associated with risk of cardiovascular death, myocardial infarction, and hospitalization for heart failure, while C-reactive protein was a less
October 2016

Highlights

The intensive intervention was initially conducted for a median of 7.8 years and used both pharmacologic and behavioral methods to target coexisting risk factors for late complications of diabetes.
September 2016

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next